|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
|
SU1181547A3
(ru)
|
1979-02-07 |
1985-09-23 |
Ф.Хоффманн-Ля Рош Унд Ко,Аг (Фирма) |
Способ получени пиримидо-2-бензазепинов или их фармакологически совместимых кислотно-аддитивных солей (и его вариант)
|
|
US4481142A
(en)
|
1979-02-07 |
1984-11-06 |
Hoffmann-La Roche Inc. |
Pyrimido-2-benzazepines
|
|
US4469633A
(en)
|
1980-05-16 |
1984-09-04 |
Hoffmann-La Roche Inc. |
N-oxides of 5-oxo-1-phenyl-2-benzazepines
|
|
EP0273697A3
(en)
|
1986-12-30 |
1989-11-29 |
Merck & Co. Inc. |
2-benzazepines with 5- and 6- membered heterocyclic rings
|
|
US5166151A
(en)
|
1988-03-25 |
1992-11-24 |
Merck & Co., Inc. |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
|
|
US5210082A
(en)
|
1991-05-16 |
1993-05-11 |
Merck & Co., Inc. |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JP2000506160A
(ja)
|
1996-03-08 |
2000-05-23 |
ゼネカ リミテッド |
神経学的に活性な試剤としてのアゾロベンズアゼピン誘導体
|
|
EP0946523A1
(en)
|
1996-12-23 |
1999-10-06 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
|
GB9713087D0
(en)
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JP3188482B2
(ja)
|
1997-09-29 |
2001-07-16 |
明治製菓株式会社 |
三環性トリアゾロベンゾアゼピン誘導体およびその製造法並びに抗アレルギー剤
|
|
US6277844B1
(en)
|
1998-09-14 |
2001-08-21 |
Sydney Spector |
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
|
|
AU4841700A
(en)
|
1999-05-12 |
2000-11-21 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
|
EP1345926B1
(en)
|
2000-12-21 |
2006-05-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6686352B2
(en)
|
2001-05-18 |
2004-02-03 |
Hoffmann-La Roche Inc. |
Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
|
|
HUP0401107A3
(en)
|
2001-08-09 |
2004-10-28 |
Actelion Pharmaceuticals Ltd |
Novel benzo-fused heterocycles, their use process for their preparation and pharmaceutical compositions containing them
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
AU2003290313B2
(en)
|
2002-12-24 |
2007-05-10 |
Astrazeneca Ab |
Phosphonooxy quinazoline derivatives and their pharmaceutical use
|
|
CA2516254A1
(en)
|
2003-02-17 |
2004-08-26 |
Pharmacia Italia S.P.A. |
Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
US7141568B2
(en)
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
DK1663242T3
(da)
|
2003-08-07 |
2011-08-01 |
Rigel Pharmaceuticals Inc |
2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
DE602005003951T4
(de)
|
2004-05-14 |
2012-10-11 |
Millennium Pharmaceuticals, Inc. |
Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
|
|
WO2005118544A2
(en)
|
2004-05-18 |
2005-12-15 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
|
US20080004270A1
(en)
|
2004-07-05 |
2008-01-03 |
Astex Therapeutics Limited |
3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors
|
|
DE602005024274D1
(de)
|
2004-07-16 |
2010-12-02 |
Sunesis Pharmaceuticals Inc |
Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
|
|
GB2420559B
(en)
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
WO2006055528A2
(en)
|
2004-11-15 |
2006-05-26 |
Rigel Pharmaceuticals, Inc. |
Process for the preparation of an optically acitive n-carbamate protected beta-lactam by optical resolution employing a candida antarctica lipase
|
|
MX2007005857A
(es)
|
2004-11-17 |
2007-10-10 |
Mikana Therapeutics Inc |
Inhibidores de cinasa.
|
|
AU2005321091B2
(en)
|
2004-12-30 |
2012-04-12 |
Astex Therapeutics Limited |
Pyrazole compounds that modulate the activity of CDK, GSK and Aurora kinases
|
|
WO2006070202A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives having kinase modulating activity
|
|
JP2008526723A
(ja)
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
|
|
US20080312223A1
(en)
|
2004-12-30 |
2008-12-18 |
Astex Therapeutics Limited |
Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
|
|
US7485661B2
(en)
|
2005-01-18 |
2009-02-03 |
Pfizer Italia S.R.L. |
Heterobicyclic pyrazole derivatives as kinase inhibitors
|
|
EP1928456B1
(en)
|
2005-09-30 |
2015-04-22 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
|
SG166827A1
(en)
|
2005-11-03 |
2010-12-29 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
|
ES2408318T3
(es)
|
2005-12-23 |
2013-06-20 |
Glaxosmithkline Llc |
Inhibidores de azaindol de las cinasas Aurora
|
|
TW200808311A
(en)
|
2006-03-30 |
2008-02-16 |
Nerviano Medical Sciences Srl |
Use of a kinase inhibitor for the treatment of particular resistant tumors
|
|
EP2026805A1
(en)
|
2006-05-08 |
2009-02-25 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
|
GB0609530D0
(en)
|
2006-05-12 |
2006-06-21 |
Cyclacel Ltd |
Combination
|
|
WO2007132221A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combined anticancer pyrimidine-thiazole aurora kinase inhibitors
|
|
WO2007132220A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder
|
|
WO2008021038A2
(en)
|
2006-08-09 |
2008-02-21 |
Millennium Pharmaceuticals, Inc. |
Pyridobenzazepine compounds and methods for inhibiting mitotic progression
|
|
CL2007003244A1
(es)
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
WO2009114703A2
(en)
|
2008-03-12 |
2009-09-17 |
Fox Chase Cancer Center |
Combination therapy for the treatment of cancer
|
|
JO3635B1
(ar)
|
2009-05-18 |
2020-08-27 |
Millennium Pharm Inc |
مركبات صيدلانية صلبة وطرق لانتاجها
|
|
JO3434B1
(ar)
|
2009-07-31 |
2019-10-20 |
Millennium Pharm Inc |
مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
|
|
CN104031049A
(zh)
|
2010-02-19 |
2014-09-10 |
米伦纽姆医药公司 |
极光激酶抑制剂的结晶形式
|
|
UY34114A
(es)
*
|
2011-06-03 |
2013-01-03 |
Millennium Pharm Inc |
Combinación de inhibidores de mek e inhibidores selectivos de la quiinasa aurora a
|
|
US20180207173A1
(en)
|
2015-07-21 |
2018-07-26 |
Millennium Pharmaceuticals, Inc. |
Administration of aurora kinase inhibitor and chemotherapeutic agents
|